Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Head and Neck Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01126008
What this trial is testing

Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Samsung Medical Center 44
Testing effectiveness (Phase 2)Study completedNCT04752384
What this trial is testing

Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Medical College of Wisconsin 20
Testing effectiveness (Phase 2)UnknownNCT04291209
What this trial is testing

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 80
Not applicableTemporarily pausedNCT02262221
What this trial is testing

Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 330
Not applicableStudy completedNCT03992664
What this trial is testing

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

Who this might be right for
Consent FormLung CancerColon Cancer+3 more
Cyprus University of Technology 40
Testing effectiveness (Phase 2)Looking for participantsNCT04278287
What this trial is testing

Chemoradiotherapy in Unresectable Esophageal Cancer

Who this might be right for
Esophageal CancerChemoradiotherapyAlbumin-bound Paxlitaxel+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 105
Testing effectiveness (Phase 2)Study completedNCT03101514
What this trial is testing

Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

Who this might be right for
Head and Neck CancerRadiotherapy
First Affiliated Hospital of Harbin Medical University 53
Early research (Phase 1)Study completedNCT02575404
What this trial is testing

GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients

Who this might be right for
MelanomaNon-Small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Providence Health & Services 36
Early research (Phase 1)Study completedNCT01325558
What this trial is testing

ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Malignant NeoplasmMalignant Solid Tumour
Altor BioScience 30
Not applicableEnded earlyNCT02421458
What this trial is testing

Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
The Netherlands Cancer Institute 36
Not applicableLooking for participantsNCT03702309
What this trial is testing

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

Who this might be right for
CancerBreast CancerLung Cancer+15 more
University Health Network, Toronto 2,500
Early research (Phase 1)Study completedNCT00858663
What this trial is testing

Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 13
Not applicableEnded earlyNCT01827709
What this trial is testing

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Universitaire Ziekenhuizen KU Leuven 11
Not applicableStudy completedNCT04286698
What this trial is testing

Two Different Physiotherapy Programs in Lymphedema Following Head and Neck Cancer Treatment

Who this might be right for
Head and Neck CancerLymphedema of FaceFibrosis; Skin
Izmir Bakircay University 21
Testing effectiveness (Phase 2)Ended earlyNCT05980598
What this trial is testing

TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Neoplasms
Ascendis Pharma A/S 27
Testing effectiveness (Phase 2)Looking for participantsNCT07807163
What this trial is testing

A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Bicara Therapeutics 160
Testing effectiveness (Phase 2)Looking for participantsNCT06636734
What this trial is testing

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown PrimaryMetastatic Head and Neck Squamous Cell Carcinoma+19 more
Emory University
Testing effectiveness (Phase 2)Study completedNCT00002964
What this trial is testing

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Roswell Park Cancer Institute
Not applicableStudy completedNCT01102621
What this trial is testing

Hearing Loss and Complaint in Patients With Head and Neck Cancer Treated With Radiotherapy

Who this might be right for
Hearing Loss
Hospital A.C. Camargo 282
Testing effectiveness (Phase 2)Study completedNCT00665392
What this trial is testing

Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer

Who this might be right for
Head and Neck Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 42
Next Page
28